AMANDA ADAMS: Open Payments
NPI 1841711165 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 52 payments from 16 companies in 2025. Trend: 2023 $1,392 · 2024 $2,111 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $235 |
| Lilly USA, LLC | 4 | $186 |
| ABBVIE INC. | 13 | $143 |
| Abbott Laboratories | 3 | $68 |
| Amgen Inc. | 4 | $62 |
| Philips North America LLC | 2 | $62 |
| PFIZER INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Corium, LLC | 2 | $43 |
Products named: Wegovy, MOUNJARO, UBRELVY, FREESTYLE LIBRE 3, OTEZLA, Cologuard Collection Kit, QULIPTA, Azstarys.
Industry payments across FL — which companies pay providers there.
